DEA Washington Division - Lunch & Learn Web-series: "Strengthening our Partnerships"

Join the DEA Washington Division for our ongoing Lunch and Learn Web-Series: "Strengthening Our Partnerships." Each month, we host 30-minute LIVE sessions featuring DEA speakers and special guests who present and discuss critical information, regulations, and procedures related to the handling, dispensing, manufacturing, distribution, and prescribing of Controlled Substances. These sessions aim to prevent diversion and reduce drug overdoses and poisonings in the District of Columbia, Maryland, and Virginia (DMV).

Audience: DEA Registrants, healthcare professionals, administrative and support personnel, local/state government officials, and students pursuing healthcare-related careers.

Registration is required. There is no registration fee. This are LIVE events and not recorded. The program is informational only and not for credit.

Any questions regarding this event may be directed to Lillianect Rivas-Mattei, Diversion Program Specialist (Outreach Coordinator) via email to: WashingtonDiversionOutreach@dea.gov

Electronic Prescription Fraud

Thursday, March 19, 2026 | 1:00 – 1:45 PM EST | WebEx - Webinar Platform

The Drug Enforcement Administration (DEA) has uncovered illegal methods used to create counterfeit electronic prescriptions, or e-scripts, for controlled substances by taking advantage of weaknesses in e-script software. Discover what the DEA has observed in their investigations and the steps that can be taken to tackle this issue.

Moderator:
Justin G. Wood - Diversion Program Manager, DEA Washington Division

Speaker:
Erin M. Hager - Senior Diversion Investigator, DEA Phoenix Division

Virtual Registration: WebEx Webinars
(capacity is limited to the first 1000 attendees)

DEA Washington Division -
Opioid Treatment Program (OTP) Healthcare Summit

Wednesday, April 15, 2026 | 9:00 AM – 12:00 PM (EST) | In-person and Virtual

The Drug Enforcement Administration - Washington Division’s Baltimore District Office will be hosting the Opioid Treatment Program (OTP) Healthcare Summit to present an overview of Controlled Substances (CS) regulations and the DEA Registrant responsibilities under the Controlled Substances Act (CSA) to ensure the proper handling of controlled prescription drugs, and the identification and prevention of diversion activity stemming from various sources. The summit brings together clinical, compliance, and public Safety leaders to strengthen Opioid Treatment delivery through regulatory clarity, operational excellence, and collaborative solutions.

Audience:

• The Summit will welcome participants from Maryland: Howard County, Baltimore County, Baltimore City, Anne Arundel County, and neighboring areas.
• Essential for professionals responsible for OTP oversight, diversion prevention, patient safety, and program Integrity. Registered DEA Narcotic Treatment Programs (including Maintenance, Detoxification, Maintenance/Detoxification, Compounder/Maintenance, Compounder/Detoxification, Compounder/Maintenance/Detoxification)
• DEA Registrants, healthcare professionals and support staff

Moderator:
Justin G. Wood - Diversion Program Manager, DEA Washington Division

Location:

James N. Robey Public Safety Training Center
2200 Scott Wheeler Dr, Marriottsville, MD 21104

WebEx Webinar Platform - Simultaneous broadcast

Virtual Registration: WebEx Webinars
(capacity is limited to the first 500 attendees)

For In-person Registration, please download and complete the PDF form and email the document to: WashingtonDiversionOutreach@dea.com
A confirmation email will be sent once your registration is successful.

In-Person Registration Form (PDF)
(capacity is limited to the first 100 attendees)

Registration is required. There is no registration fee. This is a LIVE event and not recorded. The program is informational and not for credit.

The contents of the presentations, to include speaker remarks, do not have the force and effect of law and are not meant to bind the public in any way. It is intended only for educational purposes to provide clarity to the public regarding existing resources or requirements under the law or agency policies. The statements contained during the summit that are not embodied in the law are not binding on DEA.

Any questions may be directed to Lillianect Rivas-Mattei, Diversion Program Specialist (Outreach Coordinator) via email to: WashingtonDiversionOutreach@dea.gov